FDA Investigator: Harry A. Wilson
- Harry A. Wilson first started conducting FDA inspections in 2022, with the last inspection in 2024. Over that time, Harry A. Wilson has conducted 41 inspections at 41 companies across 41 sites.
Get Harry Wilson's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Quantum Fulfillment and Support, LLC, Cedar Creek | 2024
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
FDA 483 The Fierro Group Inc. dba Rico Brands, Salt Lake City | 2024
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
FDA 483 Blue Ocean of Colorado, Inc., Denver | 2024
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
FDA 483 Signature Flight Air, Inc., Englewood | 2024
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
FDA 483 NG Zheng, Inc, Denver | 2023
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
FDA 483 Mex Hass, Denver | 2023
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
FDA 483 Abbott Laboratories, Inc, Casa Grande | 2023
Out-of-stock
Harry A. Wilson
Foods & Cosmetics Form 483
Co-Investigators (22)
- Denise Connelly, FDA Investigator
- Aryonna M. Renouf, FDA Investigator
- Eric R. Holm, FDA Investigator
- Gina M. Scholze, FDA Investigator
- Oluwaseyi Ojinni, FDA Investigator
- Solomon G. Williams, FDA Investigator
- Antonetta M. Colacchio, FDA Investigator
- Manuel A. Moreno, FDA Investigator
- Elizabeth P. Mayer, FDA Investigator
- Karen M. Labounty, FDA Investigator
- Kibily D. Dembele, FDA Investigator
- Jennifer M. Heitz, FDA Investigator
- Gary C. Pecic, FDA Investigator
- Samantha E. Rafferty, FDA Investigator
- Meaghan M. Rabideau, FDA Investigator
- Ciara J. Bajulai Austin, FDA Investigator
- Holly J. Smith, FDA Investigator
- Patricia P. Wrona, FDA Investigator
- Bajulai Austin, Ciara J, FDA Investigator
- Jessica I. Newman, FDA Investigator
- Matthew A. Johnson, FDA Investigator
- Jennifer R. Mathern, FDA Investigator